Imatron (IMAT) is up 9/16, closed at 2-17/32,
volume 6,601,700 shrs traded vs. average 900K shares daily
Today (2/8/96), Cruttenden Roth analyst William
Prather initiated coverage of the company at a buy rating.
The South San Francisco, Calif., company develops and manufactures
computed tomography scanners.
In a research note, Cruttenden said it believes the company's
ultrafast computer tomography scanning technology will
emerge as the new standard for screening patients
for coronary artery disease.
The brokerage firm estimates a loss of 11 cents a share in
1996 and net income of 7 cents in 1997, and its 12-month price
target is 4 3/4.
check it out
good luck! |
